Philadelphia, PA, United States of America

Safoora Deihimi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Institute for Cancer Research. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Safoora Deihimi. Retrieved from https://idiyas.com/inventor/safoora-deihimi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Safoora Deihimi: Innovator in Cancer Research

Introduction

Safoora Deihimi is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of cancer research, particularly in understanding the genetic mutations associated with colorectal cancer.

Latest Patents

Safoora holds a patent titled "Frequent EGFR and NTRK somatic mutations in colorectal cancer (CRC) with microsatellite instability (MSI)." This patent provides methods for identifying subjects with cancer or tumors that may be susceptible to treatment with therapeutic agents targeting EGFR-related and NTRK-related cancers. She has 1 patent to her name.

Career Highlights

Safoora is affiliated with the Institute for Cancer Research, where she applies her expertise to advance cancer treatment methodologies. Her work focuses on identifying genetic markers that can lead to more effective therapies for patients.

Collaborations

Throughout her career, Safoora has collaborated with notable colleagues, including Michael Slifker and Wafik S El-Deiry. These partnerships have enhanced her research and contributed to the advancement of cancer treatment strategies.

Conclusion

Safoora Deihimi is a dedicated inventor whose work in cancer research is paving the way for innovative treatment options. Her contributions are vital in the ongoing battle against cancer, and her patent reflects her commitment to improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…